An interventional study of Cook K-SOFT-5100 catheter and Frydman classical catheter in Infertility (IVF Patients), sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2008-10-06.
Sponsored by University Hospital, Ghent · Not applicable and Interventional
A prospective randomized trial comparing Cook K-SOFT-5100 and Frydman classical catheter 4.5 for embryo transfer in human IVF/ICSI was performed. Three experienced operators participated in the trial, using a fixed distance transfer protocol. Primary endpoint was clinical pregnancy rate, secondary endpoints were rates of difficult transfer and of catheter failure. Patients were randomized by a computer program immediately prior to embryo transfer.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 1,446 is above the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →University Hospital, Ghent is the lead sponsor of 665 studies on the registry; 156 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Cook K-SOFT-5100 catheter
Device: Cook K-SOFT-5100 catheter
Frydman classical catheter
Device: Frydman classical catheter
A Cook K-SOFT-5100 catheter was used for embryo transfer in human IVF/ICSI
A Frydman classical catheter was used for embryo transfer in human IVF/ICSI
Clinical pregnancy rates
Time frame: End of study
Rates of difficult transfer
Time frame: End of study
Catheter failure rate
Time frame: End of study
This study is completed, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Ghent